ABCL — AbCellera Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for AbCellera Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9.68	595	723	886	761
Net Total Accounts Receivable
Net Total Receivables	2.25	212	175	103	64.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12.6	813	930	1,025	872
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.48	17.9	112	217	288
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	23.5	1,006	1,319	1,541	1,488
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.89	103	121	118	119
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	13.2	175	293	308	336
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	10.3	831	1,026	1,233	1,152
Total Liabilities & Shareholders' Equity	23.5	1,006	1,319	1,541	1,488
Total Common Shares Outstanding